483 Appco Pharma Nov 2018

483 Appco Pharma Nov 2018

James Birkenstamm FDA, Nicholas Violand FDA$119.00 - Available Now

FDA investigators audited the Appco Pharma - Piscataway, NJ, United States facility and issued inspectional observations (via FDA 483) on 06 Nov 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 06 Nov 2018
  • Location: Piscataway, United States
  • FEI: 3010014758
Add To Cart